產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
400-999-210024小時(shí)服務(wù)熱線
![MNNG/HOS Cl #5 [R-1059-D] (人骨肉瘤細(xì)胞) (STR鑒定正確)](/Public/upfile/pic/xbx/CL-0492-1-1.jpg)
![MNNG/HOS Cl #5 [R-1059-D] (人骨肉瘤細(xì)胞) (STR鑒定正確)](/Public/upfile/pic/xbx/CL-0492-1-2.jpg)
![MNNG/HOS Cl #5 [R-1059-D] (人骨肉瘤細(xì)胞) (STR鑒定正確)](/Public/upfile/pic/xbx/CL-0492-1-3.jpg)
![MNNG/HOS Cl #5 [R-1059-D] (人骨肉瘤細(xì)胞) (STR鑒定正確)](/Public/upfile/pic/xbx/CL-0492-1-4.jpg)
![MNNG/HOS Cl #5 [R-1059-D] (人骨肉瘤細(xì)胞) (STR鑒定正確)](/Public/upfile/pic/xbx/CL-0492-1-5.jpg)
![MNNG/HOS Cl #5 [R-1059-D] (人骨肉瘤細(xì)胞) (STR鑒定正確)](/Public/upfile/pic/xbx/CL-0492-1-6.jpg)
![MNNG/HOS Cl #5 [R-1059-D] (人骨肉瘤細(xì)胞) (STR鑒定正確)](/Public/upfile/pic/product/cell-line-new.jpg)
MNNG/HOS Cl #5 [R-1059-D] (人骨肉瘤細(xì)胞) (STR鑒定正確)
貨號(hào)：CL-0492
規(guī)格：1×10?cells/T25培養(yǎng)瓶
價(jià)格： ￥1600
生長(zhǎng)培養(yǎng)基：MEM（含NEAA）＋10% FBS＋1% P/S
產(chǎn)品概述
| 名稱 | MNNG/HOS Cl #5 [R-1059-D] (人骨肉瘤細(xì)胞) (STR鑒定正確) |
| 別稱 | MNNG/HOS; MNNG-HOS; HOS-MNNG; MNNGHOS; MNNG-HOS (Cl#5) ; MNNG/HOS Clone F-5; MNNG; R-1059-D; TE85; TE-85; HOS-TE85; Hos TE-85; HOS TE 85; HOS TE85; HOS (TE85) ; HOS (TE85) ; HOS (TE85, Clone F5) ; MNNG-HOS (TE 85, clone F-5) ; HOS-Te85; TE 85.T; TE 85 ClF-5; TE-85 clone 5 |
| 種屬 | 人 |
| 生長(zhǎng)特性 | 貼壁細(xì)胞 |
| 細(xì)胞形態(tài) | 上皮細(xì)胞樣 |
| 凍存條件 | 凍存液：55% 基礎(chǔ)培養(yǎng)基+40%FBS+5%DMSO 溫度：液氮 |
| 培養(yǎng)方案A（默認(rèn)） |
生長(zhǎng)培養(yǎng)基:
培養(yǎng)條件:
氣相：空氣，95%；CO2，5%, 溫度：37℃
|
| 推薦傳代比例 | 1:2-1:4 |
| 推薦換液頻率 | 2-3次/周 |
| 背景描述 | MNNG/HOS Cl #5 [R-1059-D]細(xì)胞是HOS經(jīng)0.01mcg/ml MNNG(一種致癌的亞硝胺)轉(zhuǎn)化而來(lái)。MNNG/HOS Cl #5 [R-1059-D]細(xì)胞飽和濃度高，在軟瓊脂中的克隆形成率高，并能在裸鼠中成瘤。 |
| 年齡（性別） | 女性；13歲 |
| 組織來(lái)源 | 骨；骨肉瘤 |
| 細(xì)胞類型 | 腫瘤細(xì)胞 |
| 腫瘤類型 | 肉瘤細(xì)胞 |
| 生物安全等級(jí) | BSL-1 |
| 保藏機(jī)構(gòu) | ATCC; CRL-1547 ECACC; 87070201 |
STR鑒定
-
STR位點(diǎn)信息
Amelogenin X CSF1PO 12 D2S1338 24,25 D3S1358 15 D5S818 13 D7S820 11,12 D8S1179 11,14 D13S317 12 D16S539 10,13 D18S51 14 D19S433 13 D21S11 31.2 FGA 24 PentaD 9,10 PentaE 7,12 TH01 6 TPOX 8,11 vWA 18 D6S1043 18 D12S391 20 D2S441 10 -
STR鑒定圖
-
參考文獻(xiàn)
-
Chitosan based photothermal scaffold fighting against bone tumor-related complications: Recurrence, infection, and defects(2022/10/26)
作者：Yao Zhao, Xu Peng, Xiaoyang Xu
期刊：CARBOHYDRATE POLYMERS
DOI：10.1016/j.carbpol.2022.120264
影響因子 ：11.200
-
Engineered biomimetic nanoreactor for synergistic photodynamic-chemotherapy against hypoxic tumor(2022/09/22)
作者：Haoyu Guo, Lutong Wang, Wei Wu
期刊：JOURNAL OF CONTROLLED RELEASE
DOI：10.1016/j.jconrel.2022.09.020
影響因子 ：10.800
-
A mitochondria-related signature for predicting immune microenvironment and therapeutic response in osteosarcoma(2022/12/01)
作者：Lina Zhang, Song Wu, Junjie Huang
期刊：Frontiers in Oncology
影響因子 ：5.738
引用產(chǎn)品：CL-0492
-
2-Hydroxy-3-methylanthraquinone inhibits homologous recombination repair in osteosarcoma through the MYC-CHK1-RAD51 axis(2023/01/30)
作者：Doudou Jing, Xuanzuo Chen, Zhenhao Zhang
期刊：MOLECULAR MEDICINE
DOI：10.1186/s10020-023-00611-y
影響因子 ：5.700
-
A ferroptosis-related gene signature associated with immune landscape and therapeutic response in osteosarcoma.(2022/11/11)
作者：Xinxing Wang, Guang Xia, Shilang Xiao, Song Wu, Lina Zhang, Junjie Huang, Wenxiu Zhang, Xu Cao, Image_1.tif, Image_2.tif, Image_3.tif, Image_4.tif, Image_5.tif, Image_6.tif, Image_7.tif, DataSheet_1.csv, DataSheet_2.csv, DataSheet_3.csv, DataSheet_4.
期刊：Frontiers in Oncology
影響因子 ：4.700
-
PNO1 promotes the progression of osteosarcoma via TGF-β and YAP/TAZ pathway(2023/12/09)
作者：Long Fang, Baolong Wang, Zengkun Yang
期刊：Scientific Reports
DOI：10.1038/s41598-023-49295-8
影響因子 ：4.600
引用產(chǎn)品：CL-0492
-
Prognosis-related VDAC1 regulates the proliferation and apoptosis of osteosarcoma cells via the MAPK signaling pathway(2023/03/05)
作者：Xu Cai, Shaihong Zhu
期刊：Genomics
DOI：10.1016/j.ygeno.2023.110595
影響因子 ：4.400
-
Identification of an EMT-related gene-based prognostic signature in osteosarcoma(2023/04/27)
作者：Haoli Gong, Ye Tao, Sheng Xiao
期刊：Cancer Medicine
影響因子 ：4.000
-
A short peptide LINC00665_18aa encoded by lncRNA LINC00665 suppresses the proliferation and migration of osteosarcoma cells through the regulation of the CREB1/RPS6KA3 interaction(2023/06/07)
作者：Junwei Pan, Ming Liu, Xiaozong Duan
期刊：PLoS One
DOI：10.1371/journal.pone.0286422
影響因子 ：3.700
引用產(chǎn)品：164210 164210-50 CL-0236 CL-0492 PB180120 PM150210
-
Disulfidptosis-related PABPC3 promotes tumor progression and inhibits immune activity in osteosarcoma(2023/12/07)
作者：Yangbo Cao, Song Wu, Yishan Gu
期刊：JOURNAL OF GENE MEDICINE
DOI：10.1002/jgm.3641
影響因子 ：3.500
引用產(chǎn)品：CL-0492
-
Diverse cell death patterns-related signature for predicting prognosis and drug sensitivity of osteosarcoma patients(2023/10/20)
作者：Yanbin Shi, Song Wu, Xiaolin Zhang
期刊：JOURNAL OF GENE MEDICINE
DOI：10.1002/jgm.3613
影響因子 ：3.500
引用產(chǎn)品：CL-0492
-
Circular RNA circ_0096041 promotes osteosarcoma cell proliferation and migration via sponging miR-556-5p and regulating LIN28A expression(2024/02/29)
作者：Fulin Zhou, Hao Wu, Zhen Yin
期刊：CELLULAR AND MOLECULAR BIOLOGY
影響因子 ：1.600
引用產(chǎn)品：CL-0492
FAQs
Q：{{item.question}}
A：
產(chǎn)品資料
識(shí)別碼示意圖
娜胡文君.png "邱國(guó)娜/胡文君")
.png "梅文強(qiáng)")
